The EMA Endorses Controls On Immune-Regulating Medicines
Due to safety concerns, advisors to the European Medicines Agency on November 11th suggested restricting...
Australia Allows Faecal Transplants To Restore Gut Health
Australia is the first country in the world to have awarded regulatory approval for faeces...
Legal, Compliance Collab Between ProductLife And EIT Health
ProductLife Group (PLG), a supplier of regulation and compliance solutions for the life sciences sector,...
NHS Permits Potentially Life-Saving Breast Cancer Medicine
The confidential agreement reached by the NHS and the manufacturer is expected to assist up...
$2mn In The US, Gene Therapies Might Become The Standard
In recent years, the high cost of gene therapies has emerged as a major barrier...
The Reauthorization of The FDA User Fee Comes Into Effect
As anticipated, Congress swiftly reauthorized four important user fee programmes as part of a bill...
Gene Therapy Transactions Give Wall Street Cautious Optimism
Gene therapy remains a topic of fascination to biopharmaceutical dealmakers despite safety worries and opposition...
Robotic Capsules Are Here, Enhancing The Gut Drug Delivery
One of the most difficult medical research findings, drug distribution still faces a lot of...
Biopharma Mergers and Acquisitions on a Rise
Deals can be just as significant in the drug development industry as scientific advancements. Without...
EMA Follows FDA In Restricting Immune-Regulating Medicines
On October 28th, an advisory board to the European Medicines Agency advised restricting the use...
